BONESUPPORT‚Ñ¢, an emerging leader in orthobiologics for the management of bone injuries, today announces that the company is from 1 July 2020 starting direct sales within the Netherlands.
“We have a proven and scalable business model that has proved itself in a number of selected markets. We are now looking forward to adding the important Dutch market to our selected direct markets”, said Emil Billbäck, CEO of BONESUPPORT.
BONESUPPORT now has its own sales in Denmark, the Netherlands, Switzerland, the UK, Sweden and Germany. In other European markets and in other parts of the world, the company cooperates with specialist distributors. To date, BONESUPPORT has had a distributor in the Netherlands, which is allowed to sell in parallel with BONESUPPORT in the Netherlands until 31 December 2020.
